user

Novel Risk Markers and Risk Assessments for Cardiovascular Disease (vol 120, pg 133, 2017)

被引：0
|
作者：
Thomas
Lip
机构：
来源：
CIRCULATION RESEARCH | 2017年 / 120卷 / 07期
关键词：
D O I：
10.1161/RES.0000000000000142
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E30 / E30
页数：1
相关论文
共 50 条
  • [21] The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk (vol 87, pg 1602, 2008)
    Keogh, J. B.
    Clifton, P.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 88 (03): : 810 - 810
  • [22] Statins for Primary Prevention of Cardiovascular Disease (vol 58, pg 133, 2016)
    Taylor, F.
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1509): : 158 - 158
  • [23] Novel markers of cardiovascular risk in people living with HIV
    Trevillyan, J. M.
    Sallam, T.
    Moser, C.
    Currier, J. S.
    ANTIVIRAL THERAPY, 2018, 23 : A18 - A18
  • [24] Consumer Testing for Disease Risk (vol 130, pg e270, 2017)
    OBSTETRICS AND GYNECOLOGY, 2017, 130 (05):
  • [25] Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies (vol 4, pg 205, 2006)
    Goldman, Roberta E.
    Parker, Donna R.
    Eaton, Charles B.
    Borkan, Jeffrey M.
    Gramling, Robert
    Cover, Rebecca T.
    Ahern, David K.
    ANNALS OF FAMILY MEDICINE, 2006, 4 (04) : 371 - 371
  • [26] Are novel markers of cardiovascular risk worth of measure in already high risk patients?
    Kablak-Ziembicka, A.
    Przewlocki, T.
    Sliwiak, D.
    Stepien, E.
    Pieniazek, P.
    Musialek, P.
    Rzeznik, D.
    Tracz, W.
    Podolec, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 739 - 740
  • [27] Are novel markers of cardiovascular risk worth of measure in already high risk patients?
    Kablak-Ziembicka, A.
    Przewlocki, T.
    Sliwiak, D.
    Stepien, E.
    Pieniazek, P.
    Musialek, P.
    Rzeznik, D.
    Tracz, W.
    Podolec, P.
    EUROPEAN HEART JOURNAL, 2011, 32 : 739 - 740
  • [28] Comparison of SCORE and Reynolds cardiovascular risk assessments in a cohort without cardiovascular disease
    Moczar Csaba
    ORVOSI HETILAP, 2013, 154 (43) : 1709 - 1712
  • [29] Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals
    Yeboah, Joseph
    McClelland, Robyn L.
    Polonsky, Tamar S.
    Burke, Gregory L.
    Sibley, Christopher T.
    O'Leary, Daniel
    Carr, Jeffery J.
    Goff, David C., Jr.
    Greenland, Philip
    Herrington, David M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (08): : 788 - 795
  • [30] Prevalence of traditional and novel markers of cardiovascular disease risk in Scottish adolescents: socioeconomic effects
    Buchan, Duncan S.
    Ollis, Stewart
    Thomas, Non-Eleri
    Simpson, Alan
    Young, John D.
    Cooper, Stephen-Mark
    Malina, Robert M.
    Cockcroft, John R.
    Baker, Julien S.
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2012, 37 (05) : 829 - 839
12345